#breast cancer — Thursday, February 05, 2026 (1 items)
| 0 | ℹ |
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-02-05 | #clinical trial #immunotherapy #breast cancer #her2 #metastatic |